Concepedia

Ta Jen Liu

TJ

Statistics

Publications

9

Citations

812

H-Index

9

Active since

1988

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

Ta Jen Liu is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

1988–2009

9

Publications

9

In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

Gary L. Clayman, Adel K. El‐Naggar, Jack A. Roth et al. · PubMed · 1995 · 265 citations

, , +17

Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.

Seock Ah Im, Candelaria Gomez‐Manzano, Juàn Fueyo et al. · PubMed · 1999 · 141 citations

, , +17

Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma

Dimpy Koul, Ruijun Shen, Sherry Bergh et al. · Molecular Cancer Therapeutics · 2005 · 102 citations

, , +16

The Excitatory Amino Acid Transporter-2 Induces Apoptosis and Decreases Glioma Growth <i>In vitro</i> and <i>In vivo</i>

John de Groot, Ta Jen Liu, Gregory N. Fuller et al. · Cancer Research · 2005 · 95 citations · Full text

, , +17

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

Morris D. Groves, Kenneth R. Hess, Vinay K. Puduvalli et al. · Journal of Neuro-Oncology · 2009 · 82 citations

, , +13

1–5 of 9